Carter v. Wake Forest

CourtSupreme Court of Virginia
DecidedMay 9, 2024
Docket1230260
StatusPublished

This text of Carter v. Wake Forest (Carter v. Wake Forest) is published on Counsel Stack Legal Research, covering Supreme Court of Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carter v. Wake Forest, (Va. 2024).

Opinion

PRESENT: All the Justices

KATHERINE LOUISE CARTER, EXECUTOR OF THE ESTATE OF WORTH HARRIS CARTER, JR., DECEASED OPINION BY v. Record No. 230260 JUSTICE CLEO E. POWELL MAY 9, 2024 WAKE FOREST UNIVERSITY BAPTIST MEDICAL CENTER, et al.

FROM THE COURT OF APPEALS OF VIRGINIA

Katherine Louise Carter (“Ms. Carter”) appeals the decision of the Court of Appeals that

the Circuit Court for the City of Martinsville lacked personal jurisdiction over Wake Forest

University Baptist Medical Center and Wake Forest University Health Sciences (collectively,

“Wake Forest”). Concluding that Wake Forest did not purposefully avail itself of the privilege of

conducting activities in Virginia, we affirm.

I. BACKGROUND

In January 2016, Worth Harris Carter, Jr. (“Mr. Carter”) noticed a rash on his scrotum

and groin area and sought treatment with a Virginia dermatologist. After six months of

unsuccessful treatment, Mr. Carter’s primary care doctor referred him to Wake Forest in

Winston-Salem, North Carolina.

In June 2016, Mr. Carter traveled to North Carolina for an appointment with Dr. Kevin P.

High, 1 an infectious disease specialist employed by Wake Forest. Dr. High diagnosed the groin

rash as “severe perineal candidiasis” and noted the swelling, inflammation, and lesions on Mr.

1 Between June 2016 and March 2017, Mr. Carter met with Dr. High two times. Carter’s scrotum. A week later, Ms. Carter messaged Dr. High through the MyWakeHealth

portal 2 (the “portal”) to update him on her father’s condition and to ask whether Mr. Carter could

use nystatin powder with his current prescription. The same day, Dr. High responded, “I think

what you are describing is the expected evolution of this process. . . I would continue as we have

suggest[ed]. If you want to try a bit of nystatin that would be ok.” Ms. Carter asked Dr. High to

send the prescription to her local pharmacy in Virginia, and Dr. High obliged.

In mid-July 2016, Mr. Carter sought a second opinion at Johns Hopkins Hospital in

Baltimore, Maryland. The physicians at Johns Hopkins arranged for Mr. Carter to have follow-

up care with Dr. Steven Feldman, a dermatologist employed by Wake Forest. In early August,

Mr. Carter traveled to North Carolina for an appointment with Dr. Feldman, who conducted an

examination of the groin area. 3 During a follow-up appointment in mid-August, Dr. Feldman

advised Mr. Carter to apply zinc oxide to the rash and to return in two months. Two weeks later,

Ms. Carter texted Dr. Feldman photo updates of the rash. Dr. Feldman responded, “The skin

looks much better! I would keep the current treatment.” In the following days, Ms. Carter sent

additional photos to Dr. Feldman and asked for suggestions because the groin was starting to

“hurt and burn again.” Dr. Feldman suggested that Mr. Carter continue taking prednisone and

cease using olive oil soap to clean the area.

In late August 2016, Mr. Carter traveled to North Carolina for an appointment with Dr.

William B. Applegate, a gerontologist employed by Wake Forest.4 Dr. Applegate conducted an

2 This is an online patient portal used to send secure messages and access medical records. 3 Between August and December 2016, Mr. Carter met with Dr. Feldman six times. 4 Between August and October 2016, Mr. Carter met with Dr. Applegate two times.

2 assessment and referred Mr. Carter to Dr. Lucian G. Vlad, a wound care specialist employed by

Wake Forest.

In late September 2016, Mr. Carter traveled to North Carolina for an appointment with

Dr. Vlad. 5 Dr. Vlad diagnosed the condition as “ulcer of the groin, limited breakdown of the

skin, and candidiasis of the perineum.” Dr. Vlad monitored Mr. Carter’s progress and treatment

over the course of eight in-person appointments between September and December 2016, and

considered whether a biopsy was necessary. Ms. Carter initiated several scheduling calls with Dr.

Vlad’s office between appointments.

In early January 2017, Mr. Carter met with Dr. Vlad for the ninth time. Dr. Vlad noted

that Mr. Carter’s condition was “significant[ly] worsening” and that he would discuss the case

with the other doctors. Within one week, Ms. Carter messaged Dr. Vlad via the portal to inform

him that Mr. Carter was recently hospitalized, so she would have to cancel his upcoming

appointment. She also stated that the groin rash was improving. Dr. Vlad responded that he

conferred with Dr. Feldman and Dr. High, and they decided to perform a biopsy at Mr. Carter’s

next appointment. Ms. Carter provided additional updates and rescheduled the appointment.

In late January 2017, Mr. Carter met with Dr. Vlad. He conducted a physical examination

of the groin area and found the wound was improving. Dr. Vlad decided to postpone the biopsy

and continue the current treatment plan and instructed Mr. Carter to follow-up in two weeks.

Approximately three weeks later, Ms. Carter messaged Dr. Vlad via the portal to notify

him of Mr. Carter’s current hospitalization. According to Ms. Carter, the local doctor wanted her

to follow-up with Dr. Vlad and Dr. Feldman and suggested tapering off the prednisone. Ms.

5 Between September 2016 and February 2017, Mr. Carter met with Dr. Vlad eleven times.

3 Carter also confirmed that she was still applying the zinc oxide and using soap to clean the

wound. Dr. Vlad responded that he agreed with the local doctor’s recommendations and

instructed Ms. Carter to pass information along to the local doctor about Mr. Carter’s prednisone

schedule and their plan to perform a biopsy. Dr. Vlad instructed Ms. Carter to ask if the local

doctor could get a biopsy while Mr. Carter was in the hospital. Ms. Carter responded that the

local dermatology team could not see Mr. Carter until March and provided an update on Mr.

Carter’s groin. Dr. Vlad stated, “I don’t want him to see another dermatologist” and advised her

to schedule an appointment with his office within two weeks for the biopsy.

In late February 2017, Dr. Vlad performed the biopsy in North Carolina. A few days

later, Ms. Carter messaged Dr. Vlad via the portal to ask if he could call to explain the pathology

results. Dr. Vlad called and informed the Carters that the results indicated skin cancer. In early

March, 6 Mr. Carter met with Dr. High and several oncologists in North Carolina to undergo

further testing and determine a treatment plan. Mr. Carter passed away in April 2017.

In March 2019, Ms. Carter, as executor of Mr. Carter’s estate, initiated a lawsuit in the

Circuit Court of the City of Martinsville against Wake Forest, four North Carolina doctors, and a

Virginia dermatologist.7 By special appearance, Wake Forest moved to dismiss for lack of

personal jurisdiction. In response, the circuit court authorized jurisdictional discovery. Upon the

conclusion of jurisdictional discovery, Wake Forest filed an amended motion to dismiss. The

circuit court granted the amended motion to dismiss because the application of Virginia’s long

6 On March 7, 2017, the State Corporation Commission authorized Wake Forest to transact business in Virginia. 7 The four North Carolina doctors were non-suited in May 2020. The Virginia dermatologist is not a party to this appeal.

4 arm statute was inconsistent with the due process clause of the Fourteenth Amendment. The

circuit court noted the following undisputed findings of fact:

1.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Hanson v. Denckla
357 U.S. 235 (Supreme Court, 1958)
Keeton v. Hustler Magazine, Inc.
465 U.S. 770 (Supreme Court, 1984)
Mina Wright v. James Yackley
459 F.2d 287 (Ninth Circuit, 1972)
Collins v. First Union Nat. Bank
636 S.E.2d 442 (Supreme Court of Virginia, 2006)
Peninsula Cruise, Inc. v. New River Yacht Sales, Inc.
512 S.E.2d 560 (Supreme Court of Virginia, 1999)
Bergaust v. Flaherty
703 S.E.2d 248 (Court of Appeals of Virginia, 2011)
Hume v. Durwood Medical Clinic, Inc.
318 S.E.2d 119 (Court of Appeals of South Carolina, 1984)
Danville Plywood Corp. v. Plain & Fancy Kitchens, Inc.
238 S.E.2d 800 (Supreme Court of Virginia, 1977)
Prince v. Urban
49 Cal. App. 4th 1056 (California Court of Appeal, 1996)
McGee v. Riekhof
442 F. Supp. 1276 (D. Montana, 1978)
Walsh Ex Rel. Estate of Walsh v. Chez
418 F. Supp. 2d 781 (W.D. Pennsylvania, 2006)
Vance v. Molina
2001 OK 60 (Supreme Court of Oklahoma, 2001)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Ford Motor Co. v. Montana Eighth Judicial Dist.
592 U.S. 351 (Supreme Court, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Carter v. Wake Forest, Counsel Stack Legal Research, https://law.counselstack.com/opinion/carter-v-wake-forest-va-2024.